January, 2020
Phagenesis Receives FDA Breakthrough Designation For Its Phagenyx® System FDA’s Breakthrough Device Designation Program allows for priority review of the Phagenyx® System
Read MoreJuly, 2019
Promising results of Phagenyx® treatment in Orally Intubated ICU Patients with Dysphagia
Read MoreJuly, 2019
1st patient recruited and randomised in PhINEST, a new RCT to confirm the positive outcomes of Phagenyx® treatment for patients with Post-Extubation Dysphagia
Read MoreSeptember, 2018